A study for a 53 year old woman who takes Methylin, Lamotrigine - from FDA reports


Summary

97 females aged 53 (±5) who take the same drugs are studied. This is a personalized study for a 53 year old female patient who has Bipolar, Adhd. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Dec, 11, 2017

97 females aged 53 (±5) who take Methylin, Lamotrigine are studied.


Number of reports submitted per year:

Methylin, Lamotrigine for a 53-year old woman.

Information of the patient in this study:

  • Age: 53
  • Gender: female
  • Conditions: Bipolar, Adhd
  • Drugs taken:
    • Methylin (methylphenidate hydrochloride)
    • Lamotrigine (lamotrigine)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • drug hypersensitivity
  • dermatitis bullous
  • high blood pressure
  • dry mouth
  • rheumatoid arthritis
  • glossodynia
  • thirst
  • appetite - decreased
1 - 6 months:
  • memory loss
  • headache
  • balance disorder
  • rashes
  • weakness
  • carotid bruit
  • appetite - decreased
  • stress and anxiety
  • coordination abnormal
  • nausea
6 - 12 months:
  • therapeutic response unexpected
  • suicidal ideation
  • stress and anxiety
  • pre-existing condition improved
1 - 2 years:
  • heart rate decreased
  • dizziness (excl vertigo)
  • chest pain
  • fatigue
  • sensation of heaviness
  • sick sinus syndrome
  • atrioventricular block complete
  • nausea
2 - 5 years:
  • rashes
  • arthritis
  • osteoporosis
  • swollen tongue
  • osteopenia
  • cataract
  • kyphosis
  • back pain
  • disturbance in attention
  • weight decreased
5 - 10 years:
n/a
10+ years:
  • weight decreased
  • kyphosis
  • osteopenia
  • bone disorder
  • back pain
  • disturbance in attention
  • arthritis
  • impaired driving ability
  • psychomotor hyperactivity
  • memory loss
not specified:
  • memory loss
  • depression
  • headache
  • back pain
  • weight decreased
  • osteopenia
  • balance disorder
  • disturbance in attention
  • injection site pain
  • psychomotor hyperactivity

Top conditions involved for these people *:

  • Narcolepsy (12 people, 12.37%)
  • Pain (11 people, 11.34%)
  • Depression (11 people, 11.34%)
  • Osteoporosis (10 people, 10.31%)
  • Insomnia (9 people, 9.28%)

Top co-used drugs for these people *:

  • Synthroid (14 people, 14.43%)
  • Xyrem (13 people, 13.40%)
  • Neurontin (12 people, 12.37%)
  • Flexeril (12 people, 12.37%)
  • Ativan (12 people, 12.37%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Lamotrigine, Methylin, Bipolar Adhd

You may be interested in these posts

More posts for: Lamotrigine, Methylin, Bipolar Adhd